CURRICULUM VITAE Dr. med. univ. GERALD FRIEDL
CURRICULUM VITAE Dr. med. univ. GERALD FRIEDL
CURRICULUM VITAE Dr. med. univ. GERALD FRIEDL
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Gerald Friedl Seite 13 von 13<br />
Friedl G, Rehak I, Schmidt H, Aigner R, Windhager R. Mesenchymal stem cells<br />
(hMSCs) and the osteogenic mechanoresponse in obese patients. 17 th Annual<br />
Meeting of the European Orthopaedic Research Society (EORS), Apr 24-26,<br />
2008, Madrid, Spain<br />
Windhager R, Scheipl S, Friedl G. Komorbiditätsfaktor Adipositas: Knochen-<br />
und Gelenkschirurgie. 49. Österreichischer Chirurgenkongress der<br />
Österreichischen Gesellschaft für Chirurgie (ÖGC), 21. - 23. Mai 2008,<br />
Congress Innsbruck, Österreich<br />
Friedl G, Rehak I, Schmidt H, Kostner G, Stadelmeyer E, Schulz E, Aigner R,<br />
Windhager R. Resistance of undifferentiated mesenchymal stem cells (hMSCs)<br />
to the osteogenic mechanoresponse in obese patients. 9 th Congress of the<br />
European Federation of National Associations of Orthopaedics and<br />
Traumatology (EFORT), May 29 – June 1, 2008, Nice, France. Nominated for<br />
the Free Paper Award.<br />
Friedl G, Radl R, Rehak P, Windhager R. Der Effekt von Zoledronat auf das<br />
Migrationsverhalten einer zementfreien Hüfttotalendoprothese: eine<br />
unabhängige, doppel-blind randomisierte, kontrolierte Studie. Deutscher<br />
Kongress für Orthopädie und Unfallchirurgie, 22.-25.Oktober 2008, Berlin,<br />
Deutschland<br />
Friedl G, Aigner R, Windhager R. Local over whole-body antiresorptive effects<br />
of a systemically administrated bisphosphonate in total hip arthroplasty (THA) –<br />
Results from a randomized, double-blind, controlled trial. 10 th Congress of the<br />
European Federation of National Associations of Orthopaedics and<br />
Traumatology (EFORT); June 3-6, 2009. Vienna, Austria<br />
Friedl G, Radl R, Rehak P, Aigner R, Windhager R. Viability of a single infusion<br />
of zoledronic acid to reduce implant failure rate in total hip arthroplasty. 10 th<br />
Congress of the European Federation of National Associations of Orthopaedics<br />
and Traumatology (EFORT); June 3-6, 2009. Vienna, Austria. EFORT. Free<br />
Paper Award (Bronze).<br />
Graz, Oktober 2009